Optimized Metabolic Health Many patients experience faster results when underlying metabolic concerns are identified and addressed early in the process
Yes, we offer Semaglutide-based treatments, including Wegovy, depending on patient eligibility and clinical evaluation
Switching requires new titration (812 weeks), may temporarily restart GI side effects, and will need insurance reauthorization but the mechanism shift from dual to triple agonism may produce meaningful additional weight loss
Both drugs are different versions of the diabetes treatments Mounjaro and Ozempic, which are produced by Eli Lilly and Novo Nordisk, respectively
They act as filters for lymphatic fluid and as hubs where immune cells meet invading organisms or abnormal cells
But its not all smooth sailing and skinny waists